CBD Oil ELLE was created to Support Endocannabinoid Deficiency during Menopause
Menopause is a crucial event in women’s health, characterised by the cessation of ovarian function. The oestrogens deficiency exposes women to several diseases, including obesity, osteoporosis, and cardiovascular diseases and up to 48 symptoms which can severely disrupt women’s quality of life. Before we started our journey in formulating ELLE, our breakthrough CBD Oil for Menopause, we took a deep dive into researching the function of the Endocannabinoid System (ECS) and how the decline in oestrogen during mid-life transition impacts its efficiency.
What is the Endocannabinoid System?
The Endocannabinoid System, or ECS, involves three main components: endocannabinoids, receptors, and enzymes. This biological network found in the central and peripheral nervous systems permeates the entire body and regulates several physiological and cognitive processes. Known as the “master regulator” the ECS plays a significant role in energy balance, bone metabolism, muscular contractility and immune response.
The "cannabinoid" receptors in the brain — the CB1 receptors act like traffic police to control the levels and activity of most of the other neurotransmitters; to stimulate these receptors, our bodies produce molecules called endocannabinoids. The CB2 receptor, exists mostly in our immune tissues and is critical to helping control our immune functioning, and plays a vital role in modulating intestinal inflammation, contraction, and pain in inflammatory bowel conditions.
How does Menopause affect the Endocannabinoid System?
In women’s health, oestrogen is one of the hormones that facilitates proper Endocannabinoid System function. It achieves this by regulating FAAH (fatty acid amide hydrolase) levels in the blood. FAAH facilitates the breakdown of the endocannabinoid anandamide known as the bliss molecule which plays a vital role in the regulation of emotional response. As oestrogen production during menopause plummets so does the FAAH levels. The declining interactions between the ECS and oestrogen indicate that the symptoms of menopause may be increased from reduced endocannabinoid activity.
ELLE CBD Oil Boosts your Endocannabinoids so that the ECS can work more effectively
Now we know the role of the endocannabinoid system in regulating sleep, mood, pain, immune response, memory, and hunger. The ECS keeps our body well-functioning and in balance (homeostasis). When we achieve internal homeostasis, we feel in peak condition, in contrast to when the body has an endocannabinoid system that is dysregulated which is the case during menopause.
ELLE was expertly created for the 50% of women in the UK seeking out an alternative treatment to HRT to restore balance to the ECS and support some of the menopause-related symptoms that deeply impact on women’s quality of life.
When ELLE CBD oil is ingested as a daily supplement, it frees up the endocannabinoids that your body naturally produces to bind with non-cannabinoid receptors such as serotonin receptors that are known to influence pain, mood, and sleep. By treating your endocannabinoid system with ELLE CBD oil, it simply helps in the regulation of body processes so that you will feel a sense of balance restored to your life during the change.
ELLE 4000mg CBD Reduces Anxiety and Stress during Menopause
The ECS also plays a key role in protecting us against stress, another major symptom of women going through perimenopause and menopause. Encouragingly, because ELLE is a full spectrum oil, studies show that it can influence other major hormones, including cortisol, and melatonin. It is formulated with Clary Sage, a phytoestrogen known to balance hormones and carried in a powerful proprietary Ayurvedic infusion. However, it is the anti-inflammatory and calming phyto-cannabinoid and terpene interaction of the full spectrum profile that increases the therapeutic effects of ELLE with respect to restoring balance, promoting deep relaxation and sleep whilst ensuring you absorb more of the healing benefits of the CBD.